98-31066. Notice of Filing of Pesticide Petitions  

  • [Federal Register Volume 63, Number 224 (Friday, November 20, 1998)]
    [Notices]
    [Pages 64484-64489]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-31066]
    
    
    -----------------------------------------------------------------------
    
    ENVIRONMENTAL PROTECTION AGENCY
    
    [PF-836; FRL-6030-9]
    
    
    Notice of Filing of Pesticide Petitions
    
    AGENCY: Environmental Protection Agency (EPA).
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    [[Page 64485]]
    
    SUMMARY: This notice announces the initial filing of pesticide 
    petitions proposing the establishment of regulations for residues of 
    certain pesticide chemicals in or on various food commodities.
    DATES: Comments, identified by the docket control number PF-836, must 
    be received on or before December 21, 1998.
    ADDRESSES: By mail submit written comments to: Public Information and 
    Records Integrity Branch, Information Resources and Services Division 
    (7502C), Office of Pesticides Programs, Environmental Protection 
    Agency, 401 M St., SW., Washington, DC 20460. In person bring comments 
    to: Rm. 119, CM #2, 1921 Jefferson Davis Highway, Arlington, VA.
        Comments and data may also be submitted electronically to: docket@epamail.epa.gov. Follow the instructions under ``SUPPLEMENTARY 
    INFORMATION.'' No confidential business information should be submitted 
    through e-mail.
        Information submitted as a comment concerning this document may be 
    claimed confidential by marking any part or all of that information as 
    ``Confidential Business Information'' (CBI). CBI should not be 
    submitted through e-mail. Information marked as CBI will not be 
    disclosed except in accordance with procedures set forth in 40 CFR part 
    2. A copy of the comment that does not contain CBI must be submitted 
    for inclusion in the public record. Information not marked confidential 
    may be disclosed publicly by EPA without prior notice. All written 
    comments will be available for public inspection in Rm. 1132 at the 
    address given above, from 8:30 a.m. to 4 p.m., Monday through Friday, 
    excluding legal holidays.
    
    FOR FURTHER INFORMATION CONTACT: The product manager listed in the 
    table below:
    
    ------------------------------------------------------------------------
                                       Office location/
            Product Manager            telephone number          Address
    ------------------------------------------------------------------------
    Mark Dow PM-03................  Rm. 214, CM #2, 703-    1921 Jefferson
                                     305-5533, e-            Davis Hwy,
                                     mail:[email protected]   Arlington, VA
                                     .epa.gov.
    James Tompkins PM-25..........  Rm. 239, CM #2, 703-    Do.
                                     305-5697, e-
                                     mail:tompkins.james@e.
    ------------------------------------------------------------------------
    
    SUPPLEMENTARY INFORMATION: EPA has received pesticide petitions as 
    follows proposing the establishment and/or amendment of regulations for 
    residues of certain pesticide chemicals in or on various food 
    commodities under section 408 of the Federal Food, Drug, and Comestic 
    Act (FFDCA), 21 U.S.C. 346a. EPA has determined that these petitions 
    contain data or information regarding the elements set forth in section 
    408(d)(2); however, EPA has not fully evaluated the sufficiency of the 
    submitted data at this time or whether the data supports granting of 
    the petition. Additional data may be needed before EPA rules on the 
    petition.
        The official record for this notice of filing, as well as the 
    public version, has been established for this notice of filing under 
    docket control number [PF-836] (including comments and data submitted 
    electronically as described below). A public version of this record, 
    including printed, paper versions of electronic comments, which does 
    not include any information claimed as CBI, is available for inspection 
    from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal 
    holidays. The official record is located at the address in 
    ``ADDRESSES'' at the beginning of this document.
        Electronic comments can be sent directly to EPA at:
        opp-docket@epamail.epa.gov
    
    
        Electronic comments must be submitted as an ASCII file avoiding the 
    use of special characters and any form of encryption. Comments and data 
    will also be accepted on disks in Wordperfect 5.1 file format or ASCII 
    file format. All comments and data in electronic form must be 
    identified by the docket number (insert docket number) and appropriate 
    petition number. Electronic comments on notice may be filed online at 
    many Federal Depository Libraries.
    
    List of Subjects
    
        Environmental protection, Agricultural commodities, Food additives, 
    Feed additives, Pesticides and pests, Reporting and recordkeeping 
    requirements.
    
        Dated: October 27, 1998.
    
    James Jones,
    
    Director, Registration Division, Office of Pesticide Programs.
    
    Summaries of Petitions
    
        Petitioner summaries of the pesticide petitions are printed below 
    as required by section 408(d)(3) of the FFDCA. The summaries of the 
    petitions were prepared by the petitioners and represent the views of 
    the petitioners. EPA is publishing the petition summaries verbatim 
    without editing them in any way. The petition summary announces the 
    availability of a description of the analytical methods available to 
    EPA for the detection and measurement of the pesticide chemical 
    residues or an explanation of why no such method is needed.
    
    1. Bayer Corporation
    
     PP 8F5023
    
        EPA has received a pesticide petition (PP 8F5023) from Bayer 
    Corporation, 8400 Hawthorn Road, Kansas City, MO 64120, proposing 
    pursuant to section 408(d) of the Federal Food, Drug, and Cosmetic Act, 
    21 U.S.C. 346a(d), to amend 40 CFR part 180 by establishing a tolerance 
    for residues of cyfluthrin: [cyano[4-fluoro-3-phenoxyphenyl]-methyl-3-
    [2,2-dichloroethenyl]-2,2-dimethyl-cyclopropanecarboxylate] in or on 
    the raw agricultural commodity soybean, bean at 0.03 parts per million 
    (ppm); soybean, forage at 8.0 ppm; soybean, hay at 4.0 ppm; field corn, 
    forage at 3.0 ppm; and field corn, fodder at 6.0 ppm. EPA has 
    determined that the petition contains data or information regarding the 
    elements set forth in section 408(d)(2) of the FFDCA; however, EPA has 
    not fully evaluated the sufficiency of the submitted data at this time 
    or whether the data supports granting of the petition. Additional data 
    may be needed before EPA rules on the petition.
    
    A. Residue Chemistry
    
        1. Plant metabolism. The metabolism of cyfluthrin in plants is 
    adequately understood. Studies have been conducted to delineate the 
    metabolism of radiolabeled cyfluthrin in various crops all showing 
    similar results. The residue of concern is cyfluthrin.
        2. Analytical method. Adequate analytical methodology (gas/liquid 
    chromatography with an electron capture detector) is available for 
    enforcement purposes.
        3. Magnitude of residues. Cyfluthrin is the active ingredient in 
    the registered end-use product Baythroid 2 Emulsifiable Pyrethroid 
    Insecticide, EPA Reg. No. 3125-351. Data to support the proposed 
    tolerances have been submitted to the Agency.
    
    [[Page 64486]]
    
    B. Toxicological Profile
    
        1. Acute toxicity. There is a battery of acute toxicity studies for 
    cyfluthrin supporting an overall toxicity Category II for the active 
    ingredient.
        2. Genotoxicty. Mutagenicity tests were conducted, including 
    several gene mutation assays (reverse mutation and recombination assays 
    in bacteria and a Chinese hamster ovary (CHO)/HGPRT assay); a 
    structural chromosome aberration assay (CHO/sister chromatid exchange 
    assay); and an unscheduled DNA synthesis assay in rat hepatocytes. All 
    tests were negative for genotoxicity.
        3. Reproductive and developmental toxicity. An oral developmental 
    toxicity study in rats with a maternal and fetal no observed adverse 
    effect level (NOAEL) of 10 milligram/kilogram body weight/day (mg/kg/
    bwt/day) highest dose tested (HDT).
        An oral developmental toxicity study in rabbits with a maternal 
    NOAEL of 20 mg/kg/bwt/day and a maternal lowest effect level (LEL) of 
    60 mg/kg/bwt/day, based on decreased body weight gain and decreased 
    food consumption during the dosing period. A fetal NOAEL of 20 mg/kg/
    bwt/day and a fetal LEL of 60 mg/kg/ bwt/day were also observed in this 
    study. The LEL was based on increased resorptions and increased 
    postimplantation loss.
        A 3-generation reproduction study in rats with systemic toxicity 
    NOAELs of 7.5 and 2.5 mg/kg/bwt/day for parental animals and their 
    offspring, respectively. At higher dose levels (HDLs), the body weights 
    of parental animals and their offspring were reduced.
        4. Subchronic toxicity. A subchronic toxicity feeding study using 
    rats demonstrated a NOAEL of 22.5 mg/kg/bwt/day, the HDT.
        A 6 month toxicity feeding study in dogs established a NOAEL of 5 
    mg/kg/ bwt/day. The LEL was 15 mg/kg/bwt/day based on clinical signs 
    and reduced thymus weights.
        5. Chronic toxicity. A 12 month chronic feeding study in dogs 
    established a NOAEL of 4 mg/kg/bwt/day. The LEL for this study is 
    established at 16 mg/kg/bwt/day, based on slight ataxia, increased 
    vomiting, diarrhea and decreased body weight.
        A 24 month chronic feeding/carcinogenicity study in rats 
    demonstrated a NOAEL of 2.5 mg/kg/bwt/day and LEL of 6.2 mg/kg/bwt/day, 
    based on decreased body weights in males, decreased food consumption in 
    males, and inflammatory foci in the kidneys in females.
        A 24 month carcinogenicity study in mice was conducted. Under the 
    conditions of the study there were no carcinogenic effects observed. A 
    24 month chronic feeding/carcinogenicity study in rats was conducted. 
    There were no carcinogenic effects observed under the conditions of the 
    study.
        6. Animal metabolism. A metabolism study in rats showed that 
    cyfluthrin is rapidly absorbed and excreted, mostly as conjugated 
    metabolites in the urine, within 48 hours. An enterohepatic circulation 
    was observed.
        7. Metabolite toxicology. No toxicology data have been required for 
    cyfluthrin metabolites. The residue of concern is cyfluthrin.
        8. Endocrine disruption. There is no evidence of endocrine effects 
    in any of the studies conducted with cyfluthrin, thus, there is no 
    indication at this time that cyfluthrin causes endocrine effects.
    
    C. Aggregate Exposure
    
        1. Dietary exposure-- Food. Dietary exposure was estimated using 
    Novigen's Dietary Exposure Evaluation Model (DEEM) software; results 
    from field trial and processing studies; consumption data from the USDA 
    Continuing Surveys of Food Intake by Individuals (CSFIIs), conducted 
    from 1989 through 1992; and information on the percentages of crops 
    treated with cyfluthrin.
        Cyfluthrin is currently registered for use in alfalfa, carrots, 
    citrus, cotton, peppers, radishes, sorghum, sunflower, sugarcane, sweet 
    corn, and tomatoes. In addition, it has an import tolerance for hops. 
    Various formulations are registered for use in food handling 
    establishments and in combination with another active ingredient, for 
    use in field corn, pop corn and sweet corn. For potential cyfluthrin 
    use on soybeans and field corn the impact on the exposure assessment 
    was examined.
        Chronic dietary exposure estimates with the current label uses for 
    the overall U.S. population were 0.9% of the reference dose (RfD) 
    (0.008 mg/kg/ bwt/day). When soybeans, field corn and potatoes were 
    included the chronic dietary exposure estimates for the overall U.S. 
    population were 0.8% of the RfD. For the most highly exposed population 
    subgroups, non-nursing infants (<1 year)="" and="" children="" 1="" to="" 6="" years="" of="" age,="" the="" exposure="" was="" estimated="" to="" be="" 1.9%="" of="" the="" rfd="" and="" 1.8%="" of="" the="" rfd="" respectively="" for="" current="" label="" uses="" and="" 1.7%="" of="" the="" rfd="" and="" 1.7%="" of="" the="" rfd="" respectively="" for="" label="" uses="" plus="" potatoes,="" soybeans,="" field="" corn.="" the="" apparent="" drop="" in="" the="" percentage="" of="" the="" rfd="" when="" these="" uses="" are="" added="" may="" be="" explained="" by="" the="" lower="" limit="" of="" detection="" of="" the="" field="" trial="" data="" for="" these="" crops="" as="" opposed="" to="" the="" food="" handling="" data.="" acute="" dietary="" exposures="" were="" estimated="" for="" the="" overall="" u.s.="" population,="" females="" 13="" years="" and="" older,="" children,="" ages="" 1-6,="" and="" 7-12="" years,="" infants,="" non-nursing="" and="" nursing.="" the="" exposure="" was="" compared="" to="" the="" noael="" of="" 20="" mg/kg/="" bwt/day="" to="" estimate="" the="" margin="" of="" exposures="" (moes).="" for="" the="" all="" the="" population="" subgroups="" studies="" the="" 95th="" and="" 99.9th="" percentile="" of="" exposure="" the="" moes="" were="" calculated="" to="" be="" over="" 18,000="" and="" 5,000="" respectively="" for="" all="" current="" label="" uses="" and="" 9,900="" and="" 3,800="" respectively="" for="" all="" label="" uses="" plus="" potatoes,="" field="" corn="" and="" soybeans.="" for="" women="" aged="" 13="" years="" and="" older="" the="" 95th,="" and="" 99.9th="" percentile="" of="" acute="" exposure="" the="" moes="" were="" calculated="" as="" 66,746="" and="" 18,390="" respectively="" for="" all="" current="" label="" uses="" and="" 33,704="" and="" 11,516="" respectively="" for="" label="" uses="" plus="" potatoes,="" field="" corn,="" and="" soybeans.="" lastly,="" for="" the="" potentially="" highest="" exposed="" population="" subgroups,="" non-nursing="" infants=""><1 year)="" and="" children="" ages="" 1-6="" years,="" the="" 95th,="" and="" 99.9th="" percentile="" of="" acute="" exposure="" to="" the="" moes="" were="" calculated="" at="" 53,356;="" 18,346="" and="" 5,179;="" 6,319="" respectively="" for="" all="" current="" label="" uses="" and="" 19,624;="" 9,964="" and="" 3802;="" 3943="" respectively="" for="" label="" uses="" plus="" potatoes,="" field="" corn,="" and="" soybeans.="" 2.="" drinking="" water.="" cyfluthrin="" is="" immobile="" in="" soil,="" therefore,="" will="" not="" leach="" into="" groundwater.="" additionally,="" due="" the="" insolubility="" and="" lipophilic="" nature="" of="" cyfluthrin,="" any="" residues="" in="" surface="" water="" will="" rapidly="" and="" tightly="" bind="" to="" soil="" particles="" and="" remain="" with="" sediment,="" therefore="" not="" contributing="" to="" potential="" dietary="" exposure="" from="" drinking="" water.="" a="" screening="" evaluation="" of="" leaching="" potential="" of="" a="" typical="" pyrethroid="" was="" conducted="" using="" epa's="" pesticide="" root="" zone="" model="" (przm3).="" based="" on="" this="" screening="" assessment,="" the="" potential="" concentrations="" of="" a="" pyrethroid="" in="" ground="" water="" at="" 2="" meters="" are="" essentially="" zero=""><0.001 parts="" per="" billion="" (ppb).="" surface="" water="" concentrations="" for="" pyrethroids="" were="" estimated="" using="" przm3="" and="" exposure="" analysis="" modeling="" system="" (exams)="" using="" standard="" epa="" cotton="" runoff="" and="" mississippi="" pond="" scenarios.="" the="" maximum="" concentration="" predicted="" in="" the="" simulated="" pond="" was="" 52="" parts="" per="" trillion="" (ppt).="" concentration="" in="" actual="" drinking="" water="" would="" be="" much="" lower.="" based="" on="" these="" analyses,="" the="" contribution="" of="" water="" to="" the="" dietary="" risk="" estimate="" is="" negligible.="" 3.="" non-dietary="" exposure.="" non-occupational="" exposure="" to="" cyfluthrin="" may="" occur="" as="" a="" result="" of="" inhalation="" or="" contact="" from="" indoor="" residential,="" indoor="" commercial,="" and="" outdoor="" residential="" uses.="" pursuant="" to="" the="" requirements="" of="" federal="" insecticide,="" fungicide,="" and="" [[page="" 64487]]="" rodenticide="" act="" (fifra)="" as="" amended="" by="" the="" food="" quality="" protection="" act="" (fqpa)="" of="" 1996="" non-dietary="" and="" aggregate="" risk="" analyses="" for="" cyfluthrin="" were="" conducted.="" the="" analyses="" include="" evaluation="" of="" potential="" non-="" dietary="" acute="" application="" and="" post-application="" exposures.="" non-="" occupational,="" non-dietary="" exposure="" was="" assessed="" based="" on="" the="" assumption="" that="" a="" flea="" infestation="" control="" scenario="" represents="" a="" ``worst="" case''="" scenario.="" for="" the="" flea="" control="" infestation="" scenario="" indoor="" fogger,="" and="" professional="" residential="" turf="" same="" day="" treatments="" were="" included="" for="" cyfluthrin.="" deterministic="" (point="" values)="" were="" used="" to="" present="" a="" worse="" case="" upper-bound="" estimate="" of="" non-dietary="" exposure.="" the="" non-dietary="" exposure="" estimates="" were="" expressed="" as="" systemic="" absorbed="" doses="" for="" a="" summation="" of="" inhalation,="" dermal,="" and="" incidental="" ingestion="" exposures.="" these="" worst-case="" non-dietary="" exposures="" were="" aggregated="" with="" chronic="" dietary="" exposures="" to="" evaluate="" potential="" health="" risks="" that="" might="" be="" associated="" with="" cyfluthrin="" products.="" the="" chronic="" dietary="" exposures="" were="" expressed="" as="" an="" oral="" absorbed="" dose="" to="" combine="" with="" the="" non-dietary="" systemic="" absorbed="" doses="" for="" comparison="" to="" a="" systemic="" absorbed="" dose="" noael.="" results="" for="" each="" potential="" exposed="" subpopulation="" (of="" adults,="" children="" 1-6="" years,="" and="" infants=""><1 year)="" were="" compared="" to="" the="" systemic="" absorbed="" dose="" noael="" for="" cyfluthrin="" to="" provide="" estimates="" of="" moe.="" the="" large="" moes="" for="" cyfluthrin="" clearly="" demonstrate="" a="" substantial="" degree="" of="" safety.="" the="" total="" non-dietary="" moes="" are="" 3,800,="" 2,700,="" and="" 2,500="" for="" adults,="" children="" (1-6="" years),="" and="" infants=""><1 year),="" respectively.="" the="" aggregate="" moe="" for="" adults="" is="" approximately="" 3,700="" and="" the="" moes="" for="" infants="" and="" children="" exceed="" 2,400.="" the="" non-dietary="" methods="" used="" in="" the="" analyses="" can="" be="" characterized="" as="" highly="" conservative.="" this="" is="" due="" to="" the="" conservatism="" inherent="" in="" the="" calculation="" procedures="" and="" input="" assumptions.="" an="" example="" of="" this="" is="" the="" conservatism="" inherent="" in="" the="" jassercise="" methodology's="" over-="" representation="" of="" residential="" post-application="" exposures.="" it="" is="" important="" to="" acknowledge="" that="" these="" moes="" are="" likely="" to="" significantly="" underestimate="" actual="" moes="" due="" to="" a="" variety="" of="" conservative="" assumptions="" and="" biases="" inherent="" in="" the="" derivatization="" of="" exposure="" by="" this="" method.="" therefore,="" it="" can="" be="" concluded="" that="" large="" moes="" associated="" with="" potential="" non-dietary="" and="" aggregate="" exposures="" to="" cyfluthrin="" will="" result="" in="" little="" or="" no="" health="" risks="" to="" exposed="" persons.="" the="" aggregate="" risk="" analysis="" demonstrates="" compliance="" with="" the="" health-based="" requirements="" of="" the="" fqpa="" of="" 1996="" for="" the="" current="" label="" uses.="" the="" additional="" use="" of="" cyfluthrin="" on="" field="" corn="" and="" soybean="" crops="" will="" have="" no="" impact="" on="" the="" analysis="" for="" non-dietary="" exposure.="" d.="" cumulative="" effects="" bayer="" will="" submit="" information="" for="" epa="" to="" consider="" concerning="" potential="" cumulative="" effects="" of="" cyfluthrin="" consistent="" with="" the="" schedule="" established="" by="" epa="" at="" 62="" fr="" 42020="" (august="" 4,="" 1997)="" and="" other="" epa="" publications="" pursuant="" to="" the="" fqpa.="" e.="" safety="" determination="" 1.="" u.s.="" population.="" based="" on="" the="" exposure="" assessments="" described="" above="" and="" on="" the="" completeness="" and="" reliability="" of="" the="" toxicity="" data,="" it="" can="" be="" concluded="" that="" total="" aggregate="" exposure="" to="" cyfluthrin="" from="" all="" label="" uses="" plus="" soybeans="" and="" field="" corn="" will="" utilize="" less="" than="" 2%="" of="" the="" rfd="" for="" chronic="" dietary="" exposures="" and="" that="" moe="" in="" excess="" of="" 1,000="" exist="" for="" aggregate="" exposure="" to="" cyfluthrin="" for="" non-occupational="" exposure.="" epa="" generally="" has="" no="" concerns="" for="" exposures="" below="" 100%="" of="" the="" rfd,="" because="" the="" rfd="" represents="" the="" level="" at="" or="" below="" which="" daily="" aggregate="" exposure="" over="" a="" lifetime="" will="" not="" pose="" appreciable="" risks="" to="" human="" health.="" moe="" of="" 100="" or="" more="" (300="" for="" infants="" and="" children)="" also="" indicate="" an="" adequate="" degree="" of="" safety.="" thus,="" it="" can="" be="" concluded="" that="" there="" is="" a="" reasonable="" certainty="" that="" no="" harm="" will="" result="" from="" aggregate="" exposure="" to="" cyfluthrin="" residues.="" 2.="" infants="" and="" children.="" in="" assessing="" the="" potential="" for="" additional="" sensitivity="" of="" infants="" and="" children="" to="" residues="" of="" cyfluthrin,="" the="" data="" from="" developmental="" studies="" in="" both="" rat="" and="" rabbit="" and="" a="" 2-generation="" reproduction="" study="" in="" the="" rat="" can="" be="" considered.="" the="" developmental="" toxicity="" studies="" evaluate="" any="" potential="" adverse="" effects="" on="" the="" developing="" animal="" resulting="" from="" pesticide="" exposure="" of="" the="" mother="" during="" prenatal="" development.="" the="" reproduction="" study="" evaluates="" any="" effects="" from="" exposure="" to="" the="" pesticide="" on="" the="" reproductive="" capability="" of="" mating="" animals="" through="" 2-generations,="" as="" well="" as="" any="" observed="" systemic="" toxicity.="" the="" toxicology="" data="" which="" support="" these="" uses="" of="" cyfluthrin="" include:="" i.="" a="" rat="" oral="" developmental="" toxicity="" study="" in="" which="" maternal="" and="" fetal="" noaels="" of="" 10="" mg/kg/bwt/day="" hdt="" were="" observed.="" ii.="" an="" oral="" developmental="" toxicity="" study="" in="" which="" rabbits="" had="" a="" maternal="" noael="" of="" 20="" mg/kg/bwt/day="" and="" a="" maternal="" lel="" of="" 60="" mg/kg/bwt/="" day,="" based="" on="" decreased="" body="" weight="" gain="" and="" decreased="" food="" consumption="" during="" the="" dosing="" period.="" a="" fetal="" noael="" of="" 20="" mg/kg/bwt/day="" and="" a="" fetal="" lel="" of="" 60="" mg/kg/bwt/day="" were="" also="" observed="" in="" this="" study.="" the="" lel="" was="" based="" on="" increased="" resorptions="" and="" increased="" postimplantation="" loss.="" iii.="" an="" oral="" developmental="" toxicity="" study="" performed="" with="" beta-="" cyfluthrin,="" the="" resolved="" isomer="" mixture="" of="" cyfluthrin,="" has="" been="" submitted="" to="" the="" agency="" and="" is="" currently="" under="" review.="" iv.="" a="" developmental="" toxicity="" study="" in="" rats="" exposed="" via="" inhalation="" to="" liquid="" aerosols="" of="" cyfluthrin="" revealed="" developmental="" toxicity,="" but="" only="" in="" the="" presence="" of="" maternal="" toxicity.="" the="" developmental="" noael="" was="" 0.46="" mg/m3="" on="" the="" basis="" of="" reduced="" placental="" and="" fetal="" weights,="" and="" delayed="" ossification.="" the="" noael="" for="" overt="" maternal="" toxicity="" was=""><0.46 mg/m3,="" the="" lowest="" dose="" tested="" (ldt).="" in="" a="" rat="" 3-generation="" reproduction="" study,="" systemic="" toxicity="" noaels="" of="" 7.5="" and="" 2.5="" mg/kg/bwt/day="" for="" parental="" animals="" and="" their="" offspring,="" respectively,="" were="" observed.="" at="" higher="" dose="" levels,="" the="" body="" weights="" of="" parental="" animals="" and="" their="" offspring="" were="" reduced.="" another="" multiple-="" generation="" reproduction="" study="" in="" rats="" has="" been="" submitted="" to="" the="" agency="" and="" is="" currently="" under="" review.="" to="" assess="" acute="" dietary="" exposure="" and="" determine="" a="" moe="" for="" the="" overall="" u.s.="" population="" and="" certain="" subgroups,="" the="" agency="" has="" used="" the="" rabbit="" developmental="" toxicity="" study="" which="" had="" a="" maternal="" noael="" of="" 20="" mg/kg/bwt/day.="" because="" the="" toxicological="" endpoint="" is="" one="" of="" developmental="" toxicity,="" the="" population="" group="" of="" concern="" for="" this="" analysis="" was="" women="" aged="" 13="" and="" above.="" this="" subgroup="" most="" closely="" approximates="" women="" of="" child-bearing="" age.="" the="" moe="" is="" calculated="" as="" the="" ratio="" of="" the="" noael="" to="" the="" exposure.="" the="" agency="" calculated="" the="" moe="" to="" be="" over="" 600.="" generally,="" moe's="" greater="" than="" 100="" for="" data="" derived="" from="" animal="" studies="" are="" regarded="" as="" showing="" no="" appreciable="" risk.="" ffdca="" section="" 408="" provides="" that="" epa="" may="" apply="" an="" additional="" safety="" factor="" for="" infants="" and="" children.="" the="" additional="" safety="" factor="" may="" be="" used="" when="" pre-="" and="" post-natal="" threshold="" effects="" were="" observed="" in="" studies="" or="" to="" account="" for="" incompleteness="" of="" the="" toxicity="" database.="" the="" results="" of="" the="" 3-generation="" study="" in="" rats="" provided="" evidence="" suggesting="" that,="" with="" respect="" to="" effects="" of="" cyfluthrin="" on="" body="" weight,="" pups="" were="" more="" sensitive="" than="" adult="" rats.="" thus,="" the="" agency="" determined="" that="" an="" additional="" 3-fold="" uncertainty="" factor="" (uf)="" should="" be="" used="" in="" risk="" assessments="" to="" ensure="" adequate="" protection="" of="" infants="" and="" children.="" [[page="" 64488]]="" generally,="" the="" epa="" considers="" moe="" of="" at="" least="" 100="" to="" indicate="" an="" adequate="" degree="" of="" safety.="" with="" an="" additional="" 3x="" uf,="" this="" would="" be="" 300="" for="" infants="" and="" children.="" using="" the="" exposure="" assessments="" described="" above="" and="" based="" on="" the="" described="" toxicity="" data="" aggregate="" exposure="" to="" infants="" and="" children="" indicate="" a="" margin="" of="" exposure="" in="" excess="" of="" 3,800.="" thus,="" it="" can="" be="" concluded="" that="" there="" is="" a="" reasonable="" certainty="" that="" no="" harm="" will="" result="" to="" infants="" and="" children="" from="" aggregate="" exposure="" to="" cyfluthrin="" residues.="" f.="" conclusions="" the="" available="" data="" indicate="" that="" there="" is="" reasonable="" certainty="" of="" no="" harm="" from="" the="" aggregate="" exposure="" from="" all="" currently="" registered="" uses="" of="" cyfluthrin="" plus="" potatoes,="" field="" corn="" and="" soybeans.="" g.="" international="" tolerances="" there="" are="" no="" codex="" maximum="" residue="" levels="" (mrls)="" currently="" established="" for="" residues="" of="" cyfluthrin="" on="" soybean="" commodities.="" there="" is="" a="" codex="" mrls="" for="" maize="" of="" 0.05="" ppm.="" 2.="" dow="" agrosciences="" pp="" 6f4784,="" pp="" 7f4856="" epa="" has="" received="" pesticide="" petitions="" (pp="" 6f4784="" and="" pp="" 7f4856)="" from="" dow="" agrosciences,="" 9330="" zionsville="" road,="" indianapolis,="" in="" 46268-1054,="" proposing="" pursuant="" to="" section="" 408(d)="" of="" the="" federal="" food,="" drug,="" and="" cosmetic="" act,="" 21="" u.s.c.="" 346a(d),="" to="" amend="" 40="" cfr="" part="" 180="" by="" establishing="" a="" tolerance="" for="" residues="" of="" the="" herbicide="" diclosulam="" (n-="" (2,6-dichlorophenyl)-5-ethoxy-7-fluoro[1,2,4]triazolo[1,5-c]pyrimidine-="" 2-sulfonamide)="" in="" or="" on="" the="" raw="" agricultural="" commodities="" soybean="" and="" peanut="" at="" 0.02="" parts="" per="" million="" (ppm).="" epa="" has="" determined="" that="" the="" petitions="" contain="" data="" or="" information="" regarding="" the="" elements="" set="" forth="" in="" section="" 408(d)(2)="" of="" the="" ffdca;="" however,="" epa="" has="" not="" fully="" evaluated="" the="" sufficiency="" of="" the="" submitted="" data="" at="" this="" time="" or="" whether="" the="" data="" supports="" granting="" of="" the="" petition.="" additional="" data="" may="" be="" needed="" before="" epa="" rules="" on="" the="" petitions.="" a.="" residue="" chemistry="" 1.="" plant="" metabolism.="" nature="" of="" residue="" studies="" demonstrated="" that="" residues="" of="" diclosulam="" would="" not="" be="" expected="" to="" accumulate="" to="" significant="" levels="" in="" soybeans="" or="" peanuts="" grown="" on="" soil="" treated="" with="" diclosulam,="" and="" that="" it="" was="" appropriate="" to="" base="" the="" magnitude="" of="" total="" terminal="" residues="" and="" proposed="" tolerances="" only="" on="" residues="" of="" the="" parent="" compound,="" diclosulam.="" 2.="" analytical="" method.="" analytical="" method="" is="" available="" for="" the="" determination="" of="" diclosulam="" in="" soybeans="" and="" peanuts="" at="" a="" limit="" of="" quantitation="" (loq)="" of="" 0.01="" ppm="" that="" is="" suitable="" for="" the="" enforcement="" of="" the="" proposed="" tolerance="" of="" 0.02="" ppm.="" 3.="" magnitude="" of="" residues.="" no="" detectable="" residues="" of="" diclosulam="" are="" expected="" to="" result="" from="" soil="" applications="" to="" fields="" intended="" for="" soybeans="" or="" peanuts="" under="" the="" proposed="" maximum="" label="" conditions.="" on="" the="" basis="" of="" the="" limit="" of="" detection="" (lod)="" of="" 0.003="" ppm="" for="" diclosulam="" in="" the="" analytical="" method,="" a="" tolerance="" of="" 0.02="" ppm="" is="" proposed="" for="" soybeans="" and="" peanuts.="" soybeans="" and="" peanuts="" treated="" with="" 3="" times="" the="" maximum="" label="" rates="" also="" resulted="" in="" no="" detectable="" residues="" of="" diclosulam="" in="" the="" soybean="" and="" peanuts="" or="" processed="" meal="" and="" oils.="" thus,="" no="" tolerances="" are="" being="" proposed="" for="" diclosulam="" in="" any="" processed="" products.="" b.="" toxicological="" profile="" 1.="" acute="" toxicity--diclosulam="" acute="" toxicity="" is="" low.="" the="" acute="" oral="">50 in the rat is >5,000 milligrams/kilogram (mg/kg) in 
    both males and females and the acute dermal LD50 in the 
    rabbit is >2,000 mg/kg. The inhalation LC50 in the rat is 
    >5.04 mg/l of air. Diclosulam produced no indications of dermal 
    irritation in rabbits or sensitization in the guinea pig, and only very 
    slight transient eye irritation in the rabbit following acute exposure. 
    End use formulations of diclosulam have similar low acute toxicity 
    profiles.
        2. Genotoxicty. In a battery of short-term in vitro genotoxicity 
    tests (Ames, CHO/HGPRT, chromosomal aberration) and an in vivo 
    cytogenetic assay, diclosulam was negative.
        3. Reproductive and developmental toxicity. Diclosulam exhibited no 
    effects on reproduction or fetal development. No effects on 
    reproduction or fetal development in a multigeneration reproduction 
    study in rats and no effects on reproductive performance or neonatal 
    survival were seen at the highest dose tested (HDT) (limit test at 
    1,000 milligrams/kilogram/day (mg/kg/day). In a developmental toxicity 
    study in rabbits, the maternal no observed adverse effect level (NOAEL) 
    was 65 mg/kg/day and the developmental NOAEL was at least 650 mg/kg/
    day.
        4. Subchronic toxicity. Thirteen-week dietary toxicity studies in 
    rats, mice and dogs were conducted. The primary target organs 
    identified in these studies were the kidneys (rat), and the liver (rat, 
    mouse and dog). In the rat 13-week study the NOAELs were 50 mg/kg/day 
    in the male and 100 mg/kg/day in the female, based on liver 
    histopathologic evaluation in males and decreased body weights in 
    females. In the mouse, the NOAEL was 100 mg/kg/day based upon 
    hepatocellular hypertrophy. An NOAEL of 5 mg/kg/day was established in 
    the dog based upon centrilobular hepatocellular hypertrophy at 25 mg/
    kg/day. In a 21-day repeated dermal application study in rabbits, 
    diclosulam when given at a dose of 1,000 mg/kg/day produced no signs of 
    dermal irritation or systemic toxicity.
        5. Chronic toxicity. In a 2-year combined chronic toxicity/
    oncogenicity study in the rat, the NOAEL for chronic toxicity was 5 mg/
    kg/day based upon kidney effects characterized as slight, subtle 
    alteration in kidney tubular morphology, mostly within the 
    corticomedullary junction which likely represented more a physiologic 
    adaptation than a pathological change indicative of a toxic injury. 
    There was no evidence of an oncogenic response. In a 2-year dietary 
    feeding study in B6C3F1 mice conducted at 50, 100, 250 and 500 mg/kg/
    day, 50 mg/kg/day was considered the NOAEL in males and the NOAEL in 
    females based upon histologic changes in the kidney. The lesion noted 
    in male mice was a reduced vacuolation of the kidney tubular epithelium 
    at all dose levels. Decreased absolute and relative kidney weights were 
    seen at 100 mg/kg/day and above. In female mice, focal dilation with 
    hyperplasia of the lining epithelium of the renal cortical tubules was 
    seen at 100 mg/kg/day and above. There was no evidence of an oncogenic 
    response. In a 1-year chronic toxicity study in dogs, the NOAEL was 
    considered 25 mg/kg/day, the HDT. Measurable toxicity was anticipated 
    based on the results of the 13-week study in dogs; however, the only 
    treatment related effects were slight elevations in serum alkaline 
    phosphatase and creatinine levels at 25 mg/kg/day, which were 
    considered within the normal limits of variability in dogs.
        6. Animal metabolism. Metabolism studies conducted on diclosulam 
    indicated over 80% of a single or repeated dose of 5 mg/kg was 
    absorbed, while at 500 mg/kg/day, there was incomplete absorption of 
    diclosulam, with only 15-20% of the dose absorbed. Urinary elimination 
    was rapid with half-lives of approximately 7-12 hours. Sex dependent 
    differences in disposition of the 5 mg/kg dose were traced to more 
    efficient elimination of unchanged diclosulam in the female versus male 
    kidney but are of no known toxicologic significance. Due to its rapid 
    elimination, diclosulam has little potential to accumulate upon 
    repeated administration.
    
    [[Page 64489]]
    
        7. Metabolite toxicology. The residue of concern for tolerance 
    setting purposes is the parent material (diclosulam). Thus, there is no 
    need to address metabolite toxicity.
    
    C. Aggregate Exposure
    
        1. Dietary exposure--Food. For Purposes of assessing the potential 
    dietary exposure from use of diclosulam on soybeans and peanuts, a 
    conservative estimate of aggregate exposure is determined by 
    Theoretical Maximum Residue Contribution (TMRC) assuming that 100% of 
    the soybeans and peanuts have a residue of diclosulam at the proposed 
    tolerance level of 0.02 ppm. This results in an extremely conservative 
    estimate of exposure for diclosulam, because no residues are expected 
    in these commodities at the proposed maximum label rate. The potential 
    dietary exposure is obtained by multiplying the tolerance residue level 
    on soybeans and peanuts (0.02 ppm) by the consumption data which 
    estimates the amount of soybean and peanut products consumed by various 
    population subgroups. The maximum potential average daily dose (ADD) of 
    diclosulam values determined for various populations are clearly 
    significant overestimates compared with actual exposure. When ADDs are 
    compared to the Reference Dose (RfD), which uses the lowest NOAEL of 5 
    mg/kg/day from the 2-year rat chronic toxicity study and an uncertainty 
    factor of 100, the ADD for all U.S. consumers including the highest 
    exposed group, non-nursing infants under 1-year old, would 
    theoretically be exposed to about 0.1% of the RfD.
        2. Drinking water. Another potential source of dietary exposure are 
    residues in drinking water. Based upon the available field dissipation 
    and field run off studies conducted with diclosulam there is little 
    potential for exposure to diclosulam in drinking water to cause any 
    human health concern.
    
    D. Cumulative Effects
    
        There is no reliable information to indicate that diclosulam has a 
    common mechanism of toxicity with any other chemical compound or that 
    potential toxic effects of diclosulam would be cumulative with those of 
    any other pesticide chemical. Thus Dow AgroSciences believes it is 
    appropriate to consider only the potential risks of diclosulam in its 
    exposure assessment.
    
    E. Safety Determination
    
        1. U.S. population. Using the conservative exposure assumptions 
    described above, and based on the completeness and reliability of the 
    toxicity data, Dow AgroSciences has concluded that aggregate exposure 
    to diclosulam potentially can utilize about 0.1% of the RfD for non-
    nursing infants under 1-year old, theoretically the most exposed 
    population. EPA generally has no concern for exposures below 100% of 
    the RfD because the RfD represents the level at or below which daily 
    aggregate dietary exposure over a lifetime will not pose appreciable 
    risks to human health. Therefore, Dow AgroSciences concludes that there 
    is a reasonable certainty that no harm will result from aggregate 
    exposure to diclosulam residues in on soybeans and peanuts and its 
    processed products.
        The complete toxicology profile for diclosulam shows no evidence of 
    physiological effects characteristic of the disruption of the hormone 
    estrogen. Based upon this observation, diclosulam does not meet the 
    criteria for an estrogenic compound.
        2. Infants and children. In assessing the potential for additional 
    sensitivity of infants and children to residues of diclosulam, data 
    from developmental toxicity studies in rats and rabbits and a 
    multigeneration reproduction study in the rat are considered. The 
    developmental toxicity studies are designed to evaluate adverse effects 
    on the developing organism resulting from pesticide exposure during 
    prenatal development to one or both parents. Reproduction studies 
    provide information relating to effects from exposure to the pesticide 
    on the reproductive capability and potential systemic toxicity of 
    mating animals and on various parameters associated with the well-being 
    of offspring.
        FFDCA section 408 provides that EPA may apply an additional safety 
    factor for infants and children in the case of threshold effects to 
    account for pre- and post-natal toxicity and the completeness of the 
    data base. Based on the current toxicological data requirements, the 
    data base for diclosulam relative to pre- and post-natal effects for 
    children is complete. Further, for diclosulam, the NOAEL in the chronic 
    feeding study which was used to calculate the RfD (5 mg/kg/day) is 
    already lower than the NOAELs from the developmental studies in rats 
    and rabbits by a factor of more than 200-fold.
        Concerning the reproduction study in rats, there were no effects on 
    reproduction or fetal development, even at a dose over 100 times the 
    NOAEL used to establish the RfD. Therefore, Dow AgroSciences concludes 
    that an additional uncertainty factor is not needed and that the RfD at 
    0.05 mg/kg/day is appropriate for assessing risk to infants and 
    children.
        Using the conservative exposure assumptions previously described, 
    the percent RfD utilized by the aggregate (diet, and drinking water) 
    exposure to residues of diclosulam on soybeans and peanuts is 0.000051 
    mg/kg/day for non-nursing infants under 1-year old, theoretically the 
    most exposed population subgroup. Thus, based on the completeness and 
    reliability of the toxicity data and the conservative exposure 
    assessment, Dow AgroSciences concludes that there is a reasonable 
    certainty that no harm will result to infants and children from 
    aggregate exposure to diclosulam on soybeans and peanuts.
    
    F. International Tolerances
    
        There are no Codex maximum residue levels established for residues 
    of diclosulam on soybeans, peanuts or any other food or feed crop.
    [FR Doc. 98-31066 Filed 11-19-98; 8:45 am]
    BILLING CODE 6560-50-F
    
    
    

Document Information

Published:
11/20/1998
Department:
Environmental Protection Agency
Entry Type:
Notice
Action:
Notice.
Document Number:
98-31066
Dates:
Comments, identified by the docket control number PF-836, must be received on or before December 21, 1998.
Pages:
64484-64489 (6 pages)
Docket Numbers:
PF-836, FRL-6030-9
PDF File:
98-31066.pdf